Imaging was performed using a Focus 120 microPET dedicated small Alvocidib clinical trial animal PET scanner (Concorde Microsystems Inc, Knoxville, TN). These data were sorted into 2-dimensional histograms by Fourier

rebinning. The count rates in the reconstructed images were converted to activity concentration (%ID/g) using a system calibration factor (MBq/mL per cps/voxel) derived from imaging of a mouse size phantom filled with a uniform aqueous solution of 18F. Image analysis was performed using ASIPro. Statistical analysis Significant differences between groups were determined using Student’s t test (Excel 2007; Microsoft, Redmond, WA, USA). A p-value < 0.05 was considered significant. Results Cytotoxicity assay All five human gastric cancer cell lines were MK-2206 datasheet susceptible to oncolysis by GLV-1 h153 (Figure 1). The MKN-74, OCUM-2MD3, and AGS cell lines were more sensitive to viral lysis compared to MKN-45 and TMK-1 cells. All cell lines demonstrated a dose-dependent response, with greater and faster cell kill at higher MOIs. In MKN-74, OCUM-2MD3, and AGS cell A-1210477 lines, more than 90% of the cells were killed by day 9 at an MOI of 1. The MKN-74 cell line was particularly susceptible to viral oncolysis, with greater than 77% cell kill by day 9 at the lowest MOI of 0.01. Figure

1 Cytotoxicity of GLV-1 h153 against 5 human gastric cancer cell lines in vitro . All cell lines sustained significant cytotoxicity at an MOI of 1, three cell lines were sensitive at an MOI of 0.1, and two cell lines demonstrated an exquisite sensitivity to GLV-1 h153 even at the lowest MOI of 0.01. Viral replication Standard viral plaque assays demonstrated efficient viral replication of GLV-1 h153 in all gastric cancer cell lines at an

MOI of Sunitinib clinical trial 1 (Figure 2). MKN-74 demonstrated the highest viral titer with a peak titer of 1.06 × 106 PFUs per well, a 26-fold increase from initial dose, by day 7. Figure 2 In vitro quantification of viral replication by GLV-1 h153 in human gastric cancer cell lines. Virus was collected from the wells of cells infected at an MOI of 1. Viral plaque assays demonstrated efficient viral replication in all 5 cell lines, reaching the highest viral proliferation (1.06 × 106 viral plaque-forming units by day 7) in the cell line, MKN-74, which represents a 26-fold increase from its initial dose. In vivo murine xenografts therapy with GLV-1 h153 To establish the cytolytic effects of GLV-1 h153 in vivo, mice bearing MKN-74 xenografts were treated with a single dose of intratumoral injection of GLV-1 h153 or PBS. Treated tumors demonstrated sustained/continuous tumor regression over a four-week period. By day 28, the mean tumor volume of the treatment group was 221.6 mm3 (Figure 3). One animal demonstrated a complete tumor regression. In contrast, all of the control tumors continued to grow with a mean volume of 1073.